Clascoterone Cream for Facial Acneiform Rosacea

Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea

Recruiting Phase 2 Interventional Study
Papular-pustular Rosacea Papulopustular Rosacea (PPR) Papulopustular Rosacea
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
20 (estimated)
Sponsor
Narrows Institute for Biomedical Research · Other
Who this trial is looking for

This trial is looking for men and women aged 18 and older who have been diagnosed with a specific type of rosacea. Participants will use Clascoterone cream and attend study visits to help assess its effectiveness.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years or older.
  • I have been diagnosed with papulopustular rosacea.
  • I can follow study instructions and attend all visits.
  • I can provide written and verbal consent.
  • I have been using the same type of facial products for at least a month.

You may not be able to join if

  • I have a skin condition that could affect the study results.
  • I am pregnant, breastfeeding, or planning to become pregnant.
  • I am currently in another clinical trial.
  • I have used an investigational drug or device in the past 30 days.
  • I have facial hair that could affect the study's assessments.
  • I cannot communicate or cooperate due to language or mental issues.
  • I am allergic to any components of the study products.
  • I plan to use tanning devices or be excessively sun-exposed during the trial.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

To demonstrate the efficacy of Clascoterone cream 1% in reducing the size of sebaceous glands in study participants with acneiform rosacea.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Men and women ages 18+. * Diagnosis of rosacea type 2 (papulopustular). * Available and willing to comply with study instructions and attend all study visits. * Able and willing to provide written and verbal informed consent. * Subject has used the same type and brand of make-…
Contacts

Kayla N Zafar, BA

718-836-6600

kayla.zafar@va.gov

CONTACT